Patrick Lin - 01 Apr 2025 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Business - Strategy Off
Signature
/s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
01 Apr 2025
Net transactions value
-$1,983
Form type
4
Filing time
11 Apr 2025, 17:22:45 UTC
Previous filing
18 Feb 2025
Next filing
18 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +14,482 +50% 43,541 01 Apr 2025 Direct F1
transaction PCSA Common Stock Tax liability $1,983 -4,814 -11% $0.4120 38,727 01 Apr 2025 Direct
holding PCSA Common Stock 43,500 01 Apr 2025 Lin Family Trust Feb 4, 2024
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of vested restricted shares